The Link Between Gut Health and Psoriasis

The connection between the gut microbiome and psoriasis is one of the more actively researched areas in dermatology. The gut-skin axis — the bidirectional relationship between gut microbiome composition and skin inflammation — has moved from hypothesis to documented mechanism over the past decade, with multiple studies identifying consistent differences between the gut microbiota of people with psoriasis and healthy controls. This article explains what those differences are, how they translate into skin symptoms, and what dietary changes can meaningfully improve the gut environment in ways relevant to psoriasis.

The gut-skin axis — how it works

The gut microbiome — the community of trillions of bacteria, fungi, and other microorganisms living in the digestive tract — is not a passive bystander in immune function. It actively shapes systemic immune regulation through multiple mechanisms: producing short-chain fatty acids (SCFAs) that modulate inflammatory signaling, influencing the balance between pro- and anti-inflammatory T-cell populations, and maintaining the integrity of the gut barrier that separates the intestinal contents from the bloodstream.^[1]

Psoriasis is driven by dysregulated immune activation — specifically overactive Th17 cells producing IL-17 and IL-22. The gut microbiome has documented influence on Th17 cell differentiation. When the microbiome is disrupted, the balance tips toward pro-inflammatory Th17 activity, which amplifies exactly the immune pathways that drive psoriatic inflammation. This is the core of the gut-skin axis as it relates to psoriasis — not a metaphor, but a documented immunological pathway.^[1]

What gut dysbiosis looks like in psoriasis

Studies comparing the gut microbiota of people with psoriasis to healthy controls consistently find measurable differences. The most replicated findings across multiple studies include reduced bacterial diversity overall, lower abundance of bacteria that produce short-chain fatty acids (particularly butyrate-producing species like Faecalibacterium prausnitzii), reduced Akkermansia muciniphila (a species associated with gut barrier integrity), and altered Firmicutes-to-Bacteroidetes ratios.^[2]

These are not simply correlational observations. Faecalibacterium prausnitzii is specifically anti-inflammatory — it produces butyrate, which inhibits NF-κB signaling and reduces production of IL-12 and TNF-α. Its depletion in psoriasis patients is consistent with the higher inflammatory baseline seen in the condition. Akkermansia muciniphila supports gut barrier integrity — its reduction correlates with increased intestinal permeability, which is documented at higher rates in psoriasis patients than in controls.

It's worth noting that the specific microbial signatures vary somewhat across studies — this is a field where results are not fully consistent, partly due to differences in methodology, geography, and patient populations. What is consistent is the overall pattern of reduced diversity and reduced anti-inflammatory species.

The three mechanisms that connect gut to skin

What to eat — and avoid — for gut health

The dietary interventions most relevant to gut health in psoriasis are not exotic — they are the same anti-inflammatory dietary principles that improve psoriasis through other pathways. The gut-specific framing adds specificity about why certain foods matter.

Foods that support a healthy gut microbiome

Fermented foods (kefir, plain yogurt with live cultures, kimchi, sauerkraut, miso) introduce live beneficial bacteria directly. Among fermented foods, kefir has the most diverse bacterial content — it typically contains 10–15+ bacterial strains including multiple Lactobacillus and Bifidobacterium species. The key with fermented foods is consistency — beneficial bacteria from food don't permanently colonize the gut but have measurable effects during regular consumption.

Prebiotic fiber (garlic, onions, leeks, asparagus, oats, bananas, apples) feeds the beneficial bacteria already present in the gut, particularly SCFA-producing species. This is arguably more important than probiotic supplementation — introducing bacteria without the substrate to sustain them produces limited effects. A diet high in diverse plant fibers is the most reliable way to support microbiome diversity and SCFA production.

Omega-3 fatty acids directly influence gut microbiome composition in addition to their anti-inflammatory effects — sustained intake increases the abundance of beneficial Bifidobacterium and Bacteroides species while reducing pro-inflammatory bacteria. Fatty fish (salmon, mackerel, sardines), walnuts, chia seeds, and flaxseed are the primary sources.

Foods that damage gut microbiome diversity

Ultra-processed foods and refined sugar reduce bacterial diversity, deplete SCFA-producing species, and promote growth of pro-inflammatory bacteria. This is the dietary pattern most consistently associated with gut dysbiosis across multiple studies — and the same pattern most consistently associated with worse psoriasis outcomes.

Alcohol increases gut permeability directly, disrupts microbiome composition, and reduces populations of beneficial bacteria. Its effect on psoriasis is documented through multiple pathways — gut permeability is one of them, but it also directly impairs immune regulation and reduces treatment efficacy. Of all dietary factors, alcohol has the strongest and most consistent evidence for worsening psoriasis.

Artificial sweeteners have documented effects on gut microbiome composition in multiple studies — particularly sucralose, saccharin, and aspartame, which reduce beneficial Lactobacillus and Bifidobacterium populations. The clinical significance for psoriasis specifically is less established, but the microbiome disruption is documented.

Probiotics and psoriasis — what the evidence shows

Probiotic supplementation for psoriasis has been studied in a limited number of clinical trials, with mixed but generally positive results. The most studied strains are Lactobacillus acidophilus, Lactobacillus rhamnosus, and Bifidobacterium longum. Several trials have shown measurable reductions in PASI scores with probiotic supplementation over 8–12 weeks, particularly in combination with standard treatment rather than as monotherapy.^[2]

The evidence is supportive but not definitive — trial sizes are generally small, methodologies vary, and effect sizes are moderate rather than dramatic. Probiotics are most accurately understood as a useful adjunct that improves the gut environment, not as a primary psoriasis treatment. The people most likely to benefit from probiotic supplementation are those who have digestive symptoms correlating with psoriasis flares, have recently taken antibiotics, or eat a diet low in fermented foods.

For dietary probiotics versus supplements: food sources (kefir, yogurt, kimchi, sauerkraut) provide diverse bacterial strains alongside prebiotic fiber and other nutrients — the combination is generally more effective than isolated probiotic capsules. Supplements are worth considering when dietary sources are limited or when specific strains are being targeted based on the evidence.